Cellosaurus NCI-H69/LX20 (CVCL_2139)
Cell line name | NCI-H69/LX20 |
---|---|
Synonyms | H69/LX20 |
Accession | CVCL_2139 |
Resource Identification Initiative | To cite this cell line use: NCI-H69/LX20 (RRID:CVCL_2139) |
Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
Sequence variations |
|
Disease | Lung small cell carcinoma (NCIt: C4917) Small cell lung cancer (ORDO: Orphanet_70573) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_1579 (NCI-H69) |
Sex of cell | Male |
Age at sampling | 55Y |
Category | Cancer cell line |
Cross-references | |
Cell line collections (Providers) | ECACC; 96042332 |
Cell line databases/resources | CLO; CLO_0008106
cancercelllines; CVCL_2139 |
Encyclopedic resources | Wikidata; Q54908106 |
Entry history | |
Entry creation | 04-Apr-2012 |
Last entry update | 05-Oct-2023 |
Version number | 21 |